Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2

Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2

Currently, human infections with the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are accelerating the ongoing spread of the pandemic. Several innovative types of vaccines have already been developed, whereas effective options of antiviral treatments still await a scientific imp...

Full description

Bibliographic Details
Main Authors: Friedrich Hahn, Sigrun Häge, Alexandra Herrmann, Christina Wangen, Jintawee Kicuntod, Doris Jungnickl, Julia Tillmanns, Regina Müller, Kirsten Fraedrich, Klaus Überla, Hella Kohlhof, Armin Ensser, Manfred Marschall
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pathogens
Subjects:
COVID-19 pandemic
SARS-CoV-2 infection
cultured human cells
methodological development
multi-readout assay (MRA)
antiviral drug assessment
Online Access:https://www.mdpi.com/2076-0817/10/9/1076

Internet

https://www.mdpi.com/2076-0817/10/9/1076

Similar Items